New registry aims to sharpen TIPS patient selection for liver cirrhosis
NCT ID NCT04801290
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This registry follows 250 patients with decompensated liver cirrhosis who receive a TIPS procedure, a shunt placed in the liver to reduce pressure. Researchers will track survival, brain function, nutrition, and quality of life over one year. The goal is to identify which patients benefit most and to minimize complications like confusion.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Transjugular intrahepatic portosystemic shunt (TIPS) procedure
- What this could lead to
- If successful, this registry could help doctors better select which patients with liver cirrhosis benefit most from TIPS, improving survival and quality of life while reducing side effects like confusion.
- What could go wrong
- This is an observational registry, not a controlled trial, so it cannot prove cause and effect. Results may not apply to all hospitals or patients. TIPS itself carries risks like worsening confusion or liver function.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 250 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Aug 2019
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients with decompensated liver cirrhosis and an indication for TIPS placement at Hannover Medical School.
- Ages
-
18 to 99 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Liver cirrhosis * Indication for TIPS insertion * Treatment at the Department of Gastroenterology, Hepatology and Endocrinology of Hannover Medical School * Informed consent Exclusion Criteria: * Pregnancy or Lactation * Age \<18 years * Lack of Informed consent * Symptomatic anemia with Hb \<7g/dl
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Decompensated liver cirrhosis are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Hannover Medical School
RECRUITINGHanover, Lower Saxony, 30625, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heart scans could flag Who's at risk after liver shunt
- Artificial intelligence may help decide who gets a liver first
- AI may outsmart current system for liver transplant priority
- Could growth factors help repair the liver in cirrhosis?
- Could a common cholesterol drug help slow liver failure?
- New blood test could cut unnecessary transfusions in liver patients